ANIP
ANI Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.73B
P/E Ratio
23.25
EPS
$3.32
Beta
0.43
52W High
$99.50
52W Low
$56.71
50-Day MA
$76.94
200-Day MA
$81.30
Dividend Yield
—
Profit Margin
8.87%
Forward P/E
8.42
PEG Ratio
1.06
About ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.
Fundamentals
| Revenue (TTM) | $883.37M |
| Gross Profit (TTM) | $542.06M |
| EBITDA | $174.75M |
| Operating Margin | 12.00% |
| Return on Equity | 16.20% |
| Return on Assets | 3.82% |
| Revenue/Share (TTM) | $44.05 |
| Book Value | $25.80 |
| Price-to-Book | 3.08 |
| Price-to-Sales (TTM) | 1.96 |
| EV/Revenue | 2.249 |
| EV/EBITDA | 9.58 |
| Quarterly Earnings Growth (YoY) | -16.90% |
| Quarterly Revenue Growth (YoY) | 29.60% |
| Shares Outstanding | $22.41M |
| Float | $19.00M |
| % Insiders | 9.46% |
| % Institutions | 101.50% |
Analyst Ratings
Consensus ($110.62 target)
3
Strong Buy4
Buy1
HoldData last updated: 4/7/2026